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ABSTRACT.
Purpose: To reduce capsular opaciﬁcation by a peri-surgical treatment of the lens
capsule with drugs in an in vivo rabbit model. Lens-reﬁlling surgery is a potential
therapeutic intervention to treat patients with a cataract lens. The lens material is
replaced with an injectable (bio)polymer that retains the natural mechanical and
optical lens properties, therewith allowing accommodation. The occurrence of
capsular opaciﬁcation mediated by lens epithelial cells negatively aﬀects accom-
modation and vision and should be avoided in this lens restoration approach.
Methods: An in vivo rabbit animal model was used with lens replacement with a
silicone-based gel-like polymer and concurrent treatment of the lens epitheliumwith
drugs. A case-study approach was applied as both drug combinations and
implantation times were varied. The following drugs were investigated for their
potential topreventcapsularopaciﬁcation long-term: actinomycinD,methotrexate,
paclitaxel and Tween-20. All were administered in a hyaluronic acid vehicle. The
rabbits were clinically followed for periods up to 4 years postimplantation. Eyes,
corneasand lenseswere analysedpost-mortemusingMRIand confocalmicroscopy.
Results: Treatment combinations containing actinomycin D generally led to the
least appearance of capsular ﬁbrosis. The use of Tween-20 or paclitaxel without
actinomycin D resulted in much earlier and pronounced ﬁbrotic responses. The
aspect of capsular opaciﬁcation was highly variable in individual animals.
Application of the drugs in a hyaluronic acid vehicle appeared to be a safe
method that spared the corneal endothelium.
Conclusion: The feasibility of long-term prevention of ﬁbrosis over a period of
more than 4 years has been demonstrated in lens reﬁlling in the rabbit model.
Key words: accommodation – capsular opaciﬁcation – ﬁbrosis prevention – intraocular lens
lens epithelial cells – treatment
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Cataract is a frequent disorder that
leads to blindness if left untreated.
Treatment involves removal of the
clouded lens nucleus and cortex and
nowadays replacement with a intraoc-
ular lens (IOL) made of silicone or
acrylates. This IOL is placed in the
emptied lens capsule. Cataract surgery
can be regarded as highly successful
although complications are known
(Clark 2000; Saika 2004), such as the
occurrence of posterior capsular opaci-
ﬁcation, which consists of the activa-
tion, proliferation and migration of
lens epithelial cells that can enter a
classic epithelial-to-mesenchymal tran-
sition (Saika et al. 2004). The opaciﬁ-
cation occurs on the posterior side of
the implanted lens, along the lens
capsule, within the visual axis and is
treated by YAG laser application. The
described behaviour of the lens epithe-
lium is present on all parts of the lens
capsule that is in contact with the
implanted IOL. As the present IOLs
are usually not designed to be accom-
modating lenses, and the visual axis is
cleared from ﬁbrotic tissue by the YAG
laser treatment, the entire set-up is
functional in terms of restored vision.
Together with vision, accommoda-
tion can potentially be restored, as the
accommodating system with zonula
ﬁbres and capsule remains functional
also in elderly people (Strenk et al.
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1999; Stachs et al. 2002). Several
strategies have emerged in the litera-
ture, one of which is the use of
injectable, gel-like, lens material-repla-
cing polymers (Kessler 1964; Haeﬂiger
& Parel 1994; Assia et al. 1999; De
Groot et al. 2001; Koopmans et al.
2003; Nishi et al. 2009, 2014; Hao
et al. 2010, 2012; Hettlich 2010). This
method relies on a functional capsular
bag in which the gel is kept. Capsular
opaciﬁcation cannot be resolved by
laser treatment because the capsular
integrity is pivotal for both accommo-
dation and keeping the gel in place.
Therefore, in order to create a func-
tional implant, the system has to
remain free of capsular opaciﬁcation.
Feasibility of restoration of accom-
modation using injectable gel-like poly-
mers has been shown in studies
concerning in vivo rabbit and monkey
models (Stachs et al. 2011; Koopmans
et al. 2014) and in cadaver lens studies
(Hao et al. 2012). At the same time, it
has been shown that the use of accom-
modating materials can elicit a power-
ful ﬁbrotic response of the lens
epithelium (Hao et al. 2010; Koop-
mans et al. 2011), indicating that treat-
ment of the epithelium seems to be a
necessity. It cannot be ruled out, how-
ever, that choosing the proper materi-
als for lens replacement or for
interfacing the capsule may also pre-
vent opaciﬁcation (Awasthi et al.
2009). In that respect, the results
demonstrated by Hao et al. (2012)
seem to indicate that lens epithelial
cells can proliferate in the presence of
injected polysiloxane lens-reﬁlling gels,
although at the same time examination
of the fundus was no longer possible
after one month of implantation indi-
cating that a ﬁbrotic response also may
be present.
In this study, the long-term opaciﬁ-
cation response in reﬁlled lenses in vivo
in rabbits was assessed by follow-up of
lens capsule ﬁbrosis as a function of
peri-surgical treatment of the lens
epithelium with diﬀerent drugs. The
drugs were chosen for their potential to
kill cells, to prevent proliferation, to
prevent ﬁbrosis or to actively detach
cells from the capsular wall. Based on
ex vivo studies using capsulorhexis
specimens and in vivo studies in rabbits
(Sternberg et al. 2010), methotrexate
(MTX) and actinomycin D (AD) were
chosen to treat the lens epithelium. In
the performed in vivo study, it was
observed that the rabbit eyes treated
with a mixture of methotrexate/actino-
mycin D showed no posterior capsule
opaciﬁcation at 4 months whereas
without drug treatment opaciﬁcation
started 6 weeks postoperatively (Stern-
berg et al. 2010). As paclitaxel (PTX) is
commonly used for drug-eluting stents
and drug-coated balloons in vascular
intervention (Byrne et al. 2013; Peter-
sen et al. 2013), PTX was included
regarding its antiproliferative potential
to prevent posterior capsule opaciﬁca-
tion. In addition to drugs, the detergent
Tween-20 was tested for its potential to
lyse lens epithelial cells.
To ensure safe application, the drugs
were administered by incorporating
them in sodium hyaluronate (Van
Kooten et al. 2006) in a hypotonic
environment. A low osmolarity has
been shown to assist in lens epithelial
cell killing (Maloof et al. 2005). The
treatment period was set at 5 min peri-
surgically in order to control the drug
delivery and to avoid the use of a long-
term drug-delivering device (Fernandez
et al. 2004; Koopmans et al. 2006).
Long-term implantations of 7 months
and up to more than 4 years were
performed using a silicone polymer
that has been shown to be an excellent
lens replacement material in terms of
its physical, mechanical and optical
properties (Koopmans et al. 2006;
Norrby et al. 2006).
Materials and Methods
Experimental set-up
Rabbit eyes were implanted with a
ﬂexible silicone polymer that allows
accommodation. The animal study
can be considered a series of case
studies as both drug combinations
and implantation times were varied.
Before implantation, the residual lens
epithelium was treated with chemical
compounds. Three treatment groups
were evaluated with a total of 12
eyes. The treatments were as follows:
(1) AD-based (with Tween-20 or
MTX); (2) Tween-20 alone; and (3)
PTX + Tween-20. All treatment drugs
were administered in hyaluronic acid
(Healon – HA) under hypotonic con-
ditions. Apart from the macroscopic,
clinical observations, microscopic con-
focal images of both lens capsules
in situ and corneal endothelium were
made post-mortem.
Animals
The lens implantation experiments in
rabbit eyes were performed at the
University of Rostock, Germany. The
Ethics Committee of the University of
Rostock approved this study. The ani-
mal experiments were performed in
compliance with the Association for
Research in Vision and Ophthalmology
Statement for the Use of Animals in
Ophthalmic and Vision Research.
Polymer lens-reﬁlling surgery was per-
formed in eyes of New Zealand white
rabbits aged 12–15 weeks.
MRI measurements on selected rab-
bit eyes were performed at the Univer-
sity of Greifswald, Germany. Finally,
post-mortem analysis of lenses and
corneas was performed at the Univer-
sity Medical Center Groningen. Preser-
vation details for eyes and derived
tissues in the period after enucleation
from the killed rabbits are given below
in the Methods section for the diﬀerent
geographic locations in this study.
Implantation procedure
The rabbits were anesthetized with a
mixture of 30 mg/kg ketamine
hydrochloride and 5 mg/kg xylazine
hydrochloride. Before surgery, the
pupil was dilated with tropicamide
(Mydrum) and phenylephrine
hydrochloride ophthalmic solution
(Neo-Synephrine 10.0%). A 3.0 mm
clear corneal incision was created.
Heparin sodium (5000 IU/0.2 ml) was
injected into the anterior chamber,
followed by an injection of sodium
hyaluronate (1.0%, Healon). A clear
corneal paracentesis was created with a
15-degree microsurgical knife. A high-
frequency capsule opening device (Oer-
tli Instrumente AG) was used to create
a peripheral continuous curvilinear
minicapsulorhexis with a diameter of
1.5–2.0 mm approximately 2.0–
3.0 mm from the equator. Endocapsu-
lar phacoemulsiﬁcation was performed
using a Megatron I-Plus and a P2
handpiece (Geuder AG), with infusion
through a second paracentesis into the
anterior chamber. This was followed
by bimanual capsule polishing. The
empty capsular bag was treated with a
drug-loaded solution to prevent sec-
ondary cataract development (see
below). As a preparatory step, sodium
hyaluronate 2.3% (Healon 5) was
injected into the anterior chamber to
e861
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protect the corneal endothelium. The
drug-loaded ophthalmic viscosurgical
device (OVD) solution used to lyse
and/or kill the lens epithelial cells
(LECs) was then injected to inﬂate the
capsular bag (see ‘Capsular Opaciﬁca-
tion Prevention’ section below for
preparation details below). After
5 min, the drug-loaded solution was
carefully aspirated bimanually using
the phacoemulsiﬁcation device. A pur-
pose-designed silicone membrane plug
with a diameter of 2.7 mm was inserted
in the capsular bag through the capsu-
lorhexis. The empty capsular bag was
ﬁlled with the polymer through the
capsulorhexis beneath the plug by
inserting a 25-gauge cannula into the
bag and injecting the reﬁlling polymer
until the surgeon judged that the cap-
sular bag was completely ﬁlled. The
cannula was retracted, and the plug
was positioned to close the capsu-
lorhexis. The Healon 5 was ﬂushed
from the anterior chamber with bal-
anced saline solution via the incisions.
Both incisions were sutured with 10-0
nylon, and the anterior chamber was
reinﬂated with injected balanced saline
solution.
Finally, all rabbits received a sub-
conjunctival injection of gentamicin
40 mg/ml. Postoperatively, gentamicin
eye drops (10 mg/ml, Refobacin) as
well as prednisolone acetate eye drops
(Inﬂanefran Forte) and oﬂoxacin eye
drops (Floxal) were administered daily
for 14 days. Additionally, an analgesic
(novaminsulfone sodium) was given for
7 days via potable water (20 drops per
300 ml).
Follow-up procedure
Slitlamp examination and photographic
documentation were performed under
general anaesthesia (using the same
anaesthetic protocol as described above)
after 1, 3 and 6 months and then every
3 months up to 4 years postoperatively.
The corneal endothelium was analysed
using in vivo confocal laser scanning
microscopy (CLSM) (Heidelberg Retina
Tomograph II, Heidelberg Engineering
GmbH, Germany).
Capsular opaciﬁcation prevention
Prevention of capsular opaciﬁcation
was targeted by using OVD mixtures
containing active chemical compounds
dissolved/embedded in hyaluronic
acid sodium salt. (HA). DL-methotrex-
ate (MTX), actinomycin D (AD),
paclitaxel (PTX) and polysorbate 20
(Tween-20) were obtained from
Sigma-Aldrich Chemie GmbH, Tauf-
kirchen, Germany. Stock solutions of
1 9 101 M AM and PTX in ethanol
and of 1 9 101 M MTX in dimethyl-
sulphoxide were prepared, which were
further diluted with pure water to
1 9 105 M AD, PTX or MTX [cor-
responding to a nontoxic concentra-
tion of the organic solvent of 0.01%
(Cortina et al. 1997)]. As Tween-20
can be used for lysing mammalian
cells at a concentration of 0.05 to
Table 1. Lenses and corneas obtained from rabbits. Treatment and postoperative follow-up time until kill are indicated, as are the overall




animal Clinical assessment at kill
Post-mortem microscopic
state of capsular bag
Post-mortem microscopic





Iris bombata, polymer in the anterior chamber,
lens not completely ﬁlled, low PCO
Fibrosis, strands, growth





Clear anterior and posterior capsule, no/low
PCO, on posterior capsule slight ﬁbrotic
opaciﬁcation, lens thickness constant, synechia






Clear anterior and posterior capsule, no/low
PCO, slight ﬁbrotic response, rhexis with double
plug, synechia, lens thickness constant
Clear, posteriorly some
strands of cells






No/low PCO, clear anterior and posterior
capsule, lens not completely ﬁlled





11 months Lens material in anterior chamber, contact with
cornea, vascularized cornea, hazy cornea, no
capsular opaciﬁcation






Plug not in loco, lens material in anterior
chamber, contact with cornea, vascularized





Partly ﬁbrosis of cornea,





7 months Clear and well-reconstructed lens, plug in loco,
cornea clear, no vascularization
Clear lens Regular, normal
AD/Tween/HA
Rabbit 403
7 months Clear anterior capsule, plug not in loco, some



















7 months Plug in loco, polymer in the anterior chamber,
synechia, capsule not completely ﬁlled










0.5% (v/v), it was applied at 0.025%
(v/v) in the drug-containing HA.
Pure water was obtained by puriﬁ-
cation with ion-exchange resin (Ultra
Clear UV Plus, SGWasseraufbereitung
und Regenerierstation GmbH). Etha-
nol and dimethylsulphoxide were
received in analytical grade purity from
VWR International GmbH, Darm-
stadt, Germany. The HA was dissolved
in the 1 9 105 M drug or 1 9 105 M
drug/0.025% (v) Tween-20 solutions to
yield a concentration of 1% (w/w) HA.
All treatments used are summarized in
Table 1.
Lens retrieval
After diverse implantation times, the
animals were killed, their eyes removed
and ﬁxed in toto in ﬁxation
solution [3.7% paraformaldehyde in
cytoskeleton stabilization buﬀer – CS:
0.1 M Pipes, 1 mM ethylene glycol
tetra-acetic acid (EGTA), 4% (w/v)
polyethylene glycol 8000 (all Sigma),
pH 6.9]. Eyes were kept refrigerated in
this ﬁxation solution until further anal-
ysis. Alternatively, eyes were removed
and transported from the University of
Rostock to the University Medical
Center Groningen within 24 hr while




Fig. 1. Follow-up of two successfully treated rabbit lenses using an MTX/AD/HA treatment of the lens epithelium. Lenses were followed for 19 (A),
36 (B) and 42 (C) months and 15 (D), 32 (E) and 36 (F) months postoperatively, respectively [rabbits 37 (A-C) and 40 (D–F)].
(A) (B) (C)
Fig. 2. ‘Clinical’ imaging of various stages of PCO in treatment groups Tween/HA (A), Tween/AD/HA (B) and Tween/PTX/HA (C), all 3 months
postoperatively. Only (B) represents a clear lens.
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the latter case, lenses were taken out
directly after receipt and ﬁxed. Corneas
were treated according to the same
procedure. Selected eyes were enucle-
ated in Rostock, subsequently brought
to Greifswald for MRI measurements
on the same day (see below) and
directly after MRI measurements ﬁxed
before they were transported to the
University Medical Center Groningen.
T magnetic resonance imaging
In selected cases, axial globe cross sec-
tions of whole eyes were acquired ex vivo
using a 7.1 Tmagnetic resonance scanner
(ClinScan, Bruker BioScan GmbH)
according to Stachs (Stachs et al. 2011).
Eyes were measured within 12 hr of
enucleation from the killed rabbits. Eyes
were imaged using a phased array surface
coil (rat brain)with twochannels and two
coil elements for each channel. After
exploratory T2-weighted turbo spinecho
images to localize the globe within the
orbit, a high-resolution scan was per-
formed. A ﬁeld of view of 40 mm 9
40 mmwith amatrix of 320 pixels 9 320
pixels provided an in-plane resolution of
125 mm 9 125 mm. The other imaging
parameters were repetition time 2420
milliseconds, echo time 44 milliseconds
and 15 slices with a slice thickness of
700 mmandagapof 20%between slices.
The acquisition timewas 4:43 min for the
exploratory scan and 16:04 min for the
ﬁnal high-resolution data set scan, with
an overall scanning time of approxi-
mately 30 min per rabbit eye. Eyes were
subsequently put in ﬁxation solution and
transported to the University Medical
Center Groningen for further micro-
scopic analysis.
Microscopic assessment of lenses and
corneas
For ﬂuorescence microscopy, complete
lenses and corneas were permeabilized
for respectively 15 and 3 min in 0.5%
Triton X-100 in phosphate buﬀer saline
(PBS: NaCl 137 mM, KH2PO4 1.47 mM,
Na2HPO4 8.10 mM, KCl 2.68 mM) and
stained for nuclei (DAPI, 4 lg/ml) and
the cell cytoskeleton (TRITC-Phalloi-
din, 2 lg/ml). Specimens were observed
with confocal laser scanningmicroscopy
(LEICA TCS SP2) using a fully water-
immersed LEICA 40X objective with
NA 0.80. Lenses were observed intact,
with the reﬁll material still in position in
the lens capsule. Images were taken
from both the anterior and posterior
sides. Corneas were sliced into four
quarters using a scalpel in order to be
able to adequately approach the con-
cave endothelial cell layer. Two images
were taken from each quarter, giving a
total of eight images.
Results
Surgery and macroscopic follow-up
Lens-reﬁlling surgery was performed in
12 eyes of 12 rabbits in three diﬀerent
treatment groups and resulted in suc-
cessfully reﬁlled lenses in all cases. No
complications occurred during surgery.
During the follow-up, the occurrence of
capsular opaciﬁcation was monitored
up to 4 years after surgery using slit-
lamp examination. Animals were killed
when opaciﬁcation was observed to a
signiﬁcant extent. Postoperative compli-
cations also resulted in animal kill.
Posterior synechiae were detected in
the plug area in some cases. Examples
of clear lenses more than 3 years after
lens reﬁlling are shown in Fig. 1,
whereas in Fig. 2 examples of lenses
showing diﬀerent grades of PCO are
shown three months postoperatively.
The inﬂuence of the treatment on
PCO formation is clearly illustrated by
the absence in the Tween/actinomycin
D treatment and the abundant presence
in the treatment groups with Tween-20
alone or Tween-20 and paclitaxel
together. In Fig. 3, MRI images are
shown demonstrating the contours of
the reﬁlled lens relative to the lens
shape in the control eye. These images
were made after implantation and pres-
ence in the eye for 3 years and
9 months and may not represent the
original shape directly after reﬁlling.
Lens epithelial cell response
Lens epithelium was ﬂuorescently
labelled in the intact lens and observed
with confocal microscopy. Representa-
tive images are shown inFigs 4 and 5 for
reﬁlled lenses in the diﬀerent treatment
groups and in Fig. 6 for control lenses.
Furthermore in Fig. 7, a detailed com-





Fig. 3. Transversal and sagittal MR images exemplifying the lens shape of the crystalline, original




strand in the MTX/AD/HA group after
4 years and 3 months of implantation.
Results are summarized in Table 1. A
large diversity in the presence of capsu-
lar opaciﬁcation and characteristics has
been observed.
Corneal endothelial cell response
Corneas were ﬂuorescently labelled and
observed with confocal microscopy.
When the endothelial layers are con-
sidered that can be counted, in general
the number and distribution of corneal
endothelial cells were comparable in
reﬁlled eyes and control eyes, as shown
in Fig. 8, without signiﬁcant diﬀer-
ences. Representative confocal images
are shown in Fig. 9 for treated and
control eyes. From these ﬁgures, it can
be seen that most corneas demonstrate
a homogeneous layer of endothelium
without signs of damage. Only three
corneas are damaged. Results are sum-
marized in Table 1.
Discussion
In this study, rabbit lenses were reﬁlled
with a silicone polymer that potentially
allows accommodation (Koopmans
et al. 2006). Apart from its transla-
tional use towards clinical applications,
it may also serve as an excellent model
to study the process of ﬁbrosis (Eldred
et al. 2011). In order to control opaci-
ﬁcation of the lens capsule by lens
epithelium, the interior capsular wall
was treated with diﬀerent drug combi-
nations during a peri-surgical time
window of 5 min. Results demonstrate
the feasibility of a long-term preven-
tion of ﬁbrosis, that is over a period of
more than 4 years in the rabbit in vivo
eye lens model.
The concept of replacing the stiﬀ
presbyopic lens with a material or lens





Fig. 4. Representative CLSM images of lens
epithelium in the AD /HA treatment groups,
combined with either Tween or MTX. Long-
term implantation gave little cell proliferation
and transformation as seen in (A) and (B)
representing rabbit 40 on the anterior side
towards the equator. Posteriorly, some cell
aggregates were formed also located in the
periphery (C: rabbit 37 and D: rabbit 40). Note
the diﬀerence in morphology and cell size
between both micrographs. With shorter
implantation duration, the presence of cells
on the anterior side was very limited (E: rabbit
300; F: rabbit 301), whereas posteriorly net-
work formation could be seen in diverse stages
(G: rabbit 301, near the equator; H: rabbit
403). The images in G and H together with
those in C and D show the broad range of
possibilities lens epithelial cells have in
responding to the presence of the silicone.
Each image represents 375 9 375 lm2.
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crystalline lens to restore accommoda-
tion is not new. Details of several
techniques have been published (Nishi
et al. 2009). Results reported here are
derived from a number of case studies
of accommodating lens implantations
in rabbit eyes, that were treated with
diﬀerent drug regimes, and were fol-
lowed for diﬀerent lengths of time. The
implanted silicone-based accommodat-
ing lenses were present in the animals
between 7 months and more than
4 years. Despite these variations in
implantation time, a clear picture
emerges from these experiments. Treat-
ment with drug combinations including
actinomycin D can result in the pre-
vention of ﬁbrosis, although some







Fig. 6. Representative CLSM images of lens
epithelium in control lenses. A perfectly orga-
nized lens epithelial cell monolayer is present
(A). Imaging near the apical surface of the
epithelium demonstrates the highly irregular
cytoskeletal network underneath the cell mem-
brane (B). Each image represents
375 9 375 lm2.
Fig. 5. Representative CLSM images of lens
epithelium in the Tween/HA and PTX/Tween/
HA group. A thick, clearly ﬁbrotic tissue is
present on the anterior side in the central
region, often with large cells that indicate
epithelial-to-mesenchymal transition (A, B:
rabbit 400; E, F: rabbit 405). Also posteriorly,
cells have advanced to the central region (C, D:
rabbit 400; G, H: rabbit 405). Each image
represents 375 9 375 lm2.
e866
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Tween-20 alone does not prevent the
occurrence of ﬁbrosis in any way. The
same is true for the combination of
paclitaxel and Tween-20. Within the
treatment groups with actinomycin D,
lenses were observed that were still
clear at the end of the follow-up period.
Other rabbits in these groups showed
signs of ﬁbrosis ranging from initial
stages to more mature stages. In this
respect, the implantation time is impor-
tant for the interpretation given to the
data. The MTX + AD lenses showed
signs of ﬁbrosis in two out of three
lenses, but this ﬁbrosis was minor when
compared with the Tween-20 group.
The MTX + AD rabbits walked
around with the implants for over
4 years, whereas the Tween-20 rabbits
had to be killed 7 months after implan-
tation based on the clinical assessment
of level of ﬁbrosis at that point in time.
Another actinomycin D group showed
signs of beginning ﬁbrosis in two out of
three lenses after one year, at which
point it was decided to kill this group in
order to compare the response with
that of the Tween-20 group. Despite
the beginning ﬁbrosis, the result of
AD-containing treatment is far better
than the result of Tween-20 or the PTX
treatment. Taken together, the data
indicate that AD-containing treatment
strategies have the potency to prevent
ﬁbrosis in rabbits. As pointed out by
Wormstone, the rabbit in vivo model is
often chosen due to the rapid onset and
PCO severity in this species (Worm-
stone & Eldred 2016). At the same
time, it is realized that drugs that are
eﬃcient against PCO in rabbits may
not act accordingly in other species
(Koopmans et al. 2014; Wormstone &
Eldred 2016).
In the literature, a plethora of meth-
ods has been proposed to prevent
opaciﬁcation from occurring, both in
classical intraocular lens implantations
and in accommodating lens strategies.
Proposed and investigated methods
include the use of mitomycin C, 5-
ﬂuorouracil, EDTA, acetic acid, ultra-
pure water, Triton X-100, mibefradil,
dexamethasone, diclofenac, RGD pep-
tides, alkylphosphocholines and also
drugs successfully used in other
implant systems such as the drug-
eluting stents (Beck et al. 2001; Inan
et al. 2001; Fernandez et al. 2004;
Maloof et al. 2005; Abdelwahab et al.
2006; Joner et al. 2006; L€uscher et al.
2007; Eibl et al. 2009). Many aspects of
cell adhesion, growth and signalling
have been targeted. Altogether, it can
be expected that only a few drugs may
be able to permanently stop the EMT
process when administered during a 5-
min peri-surgical treatment window,
and actinomycin D seems to have this
ability.
Regeneration of a capsule-like struc-
ture as shown by Saika et al. (2001)
was not observed in the experiments
reported in this study. Fibrosis seems
to be easily introduced when lens
epithelial cells interact with silicone
chemistry (Saika 2004; Hao et al.
2010), although the stiﬀness of the
material can be of inﬂuence. In his
early demonstration of the feasibility of
lens reﬁlling, Kessler used non-medical
grade silicone oil in combination with
silastics and observed lower rates of
PCO (Kessler 1964). The intrinsic
material stiﬀness may combine with
the extent of ﬁlling and therefore the
capsular tension. These mechanical
inﬂuences may be crucial for epithelial
cell behaviour, as demonstrated by
several recent studies on cell–material
interactions (Kim & Asthagiri 2011).
Fibrosis also appears when lenses in
rabbits are reﬁlled with sodium hyalur-
onate, although the ﬁbrosis then can
occur together with lens regeneration
(Fernandez et al. 2004). It is interesting
to note that ﬁlling with hyaluronic acid
resulted in the fastest ﬁbrosis response
and that prior treatment with distilled
water resulted in well-organized lens
regrowth. This is in contrast with the
conclusion in the 2014 JCRS publica-
tion from Koopmans that no capsular
bag ﬁbrosis occurred in the monkey
model in the presence of hyaluronate
after chemical pretreatment with AD/
MTX/Cape/HA (Koopmans et al.
2014). From the results, it is not
possible to conclude whether a sub-
population of lens epithelial cells is
responsible for transition towards
ﬁbrosis. Quiescent, germinative and
diﬀerentiating lens epithelial cell popu-
lations all possess some amount of
telomerase activity (Colitz et al. 1999)
Fig. 7. Composite CLSM image of lens epithe-
lium in the MTX/AD/HA treatment group
after 4 years and 3 months of implantation in
rabbit 37. The image represents
1.50 9 1.50 mm2. The transformed cells have
built strands of tissue with active growth cones
into the silicone lens-reﬁlling material. Fig. 8. Eﬀect of lens capsular treatment on the density of cornea endothelium per ﬁeld of view.
Cell densities were calculated for those corneas that possessed a reasonably intact endothelial







Fig. 9. Cornea endothelium of eyes with treated and ﬁlled lenses (A–I) and of control eyes (J–L). Damage to various degrees can be observed in
images G-I of AD-containing treatment groups. Damage is also observed in one of the control eye corneas (L). Each image represents
375 9 375 lm2.
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indicating that all have regenerative
potential. Furthermore, the cells have
been shown to be able to grow on the
collagen capsule (Wormstone et al. 1997;
Burger et al. 2008) provided they can
migrate into the space between capsule
and silicone gel. In this study, examples
are shown of cells migrating into the
silicone, indicating that they are able to
push the gel aside. The use of a gel may
impede the proposed no space–no cells
hypothesis reported in the literature
(Assia et al. 1999). This is corroborated
by observations that space ﬁlling with
HealonGVafter IOL implantation is not
associated with a lower rate of PCO. In
this context, it can be noted that in the
reﬁllingexperiments in rabbits thenatural
lens volumes couldnot be achieveddue to
incomplete reﬁlling of the lens capsule
intra-operatively despite silicone-plug
sealing of the microcapsulorhexis. Using
7.1 T MRI, we have shown that further
eﬀorts are necessary to optimize the
intraoperative reﬁllingof the lens capsule,
at least in rabbit eyes. The variation in the
degreeofreﬁllingmayhavecontributedto
variation in the observed ﬁbrotic
responses, but cannot explain the
observed diﬀerences in ﬁbrotic responses
associated with the use of the diﬀerent
treatments. It most likely contributes to
variations in ﬁbrosis observed within the
diﬀerent treatment groups.
A successful prevention of ﬁbrosis
must be combined with a safe applica-
tion of the treatment regime. The
corneal endothelial cells are a sensitive
marker of potential damage either by
surgical intervention in the anterior eye
chamber or by administration of toxic
compounds in the capsular bag that
may leach to other structures in the
anterior eye. Corneal endothelium is
clinically inspected to assess potential
damage as a result of ophthalmologic
intervention. Macroscopic signs of
damage include corneal clouding,
which results from or is associated with a
destruction of the endothelial cell layer
(Koopmans et al. 2011). Microscopic
inspection of the endothelial layers can
indicate early signs of damage in the
endothelial layer. In the treatment groups
in this study, the corneas generally were
not damaged by the treatment and
surgery. Starting damage was seen in
one case with MTX +AD treatment and
one case with Tween-20 + AD. In two
other cases, the inﬂux of aberrant cell
groups into the corneal tissue was
observed, one of which was due to an
inﬂammatory response. Strangely, one of
the control eyes demonstrated a heavily
disturbed corneal endothelium. This con-
cerned a rabbit with a three-year
follow-up. Data demonstrated that
drug administration through the Hea-
lon vehicle can be a safe procedure for
treating just the lens epithelial cells.
Summarizing, in this study the fea-
sibility of a long-term prevention of
ﬁbrosis, that is over a period of more
than 4 years in the rabbit model, has
been demonstrated for the use of a
peri-surgical treatment of the inner lens
capsular bag with actinomycin D
incorporated in hyaluronic acid. The
use of Tween-20 and/or paclitaxel does
not result in reduced capsular ﬁbrosis.
This creates opportunities for replacing
the stiﬀ presbyopic lens with a bioma-
terial that simulates the optical and
biomechanical properties of the young
crystalline lens to restore both vision
and accommodation.
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